Moderately bullish activity in Novo Nordisk (NVO), with shares up $3.27, or 7.19%, near $48.65. Options volume running well above average with 168k contracts traded and calls leading puts for a put/call ratio of 0.44, compared to a typical level near 0.8. Implied volatility (IV30) is higher by 0.0 points near 41.45,and below the 52wk median, suggesting an expected daily move of $1.27. Put-call skew steepened, indicating increased demand for downside protection, following a downgrade to Neutral at UBS.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Video: Why Eli Lilly Is Underperforming Today
- BofA defends Eli Lilly following selloff on weight loss pill trial data
- Eli Lilly stock move ‘way overdone,’ says BofA
- Leerink downgrades Eli Lilly with thesis changed after results for orforglipron
- Novo’s Wegovy, Eli’s Mounjaro sales for July double in India, Reuters says